ResMed (NYSE: RMD) counsel surrenders shares for RSU tax withholding

Rhea-AI Filing Summary

ResMed Inc Global General Counsel Michael J. Rider reported a small tax-related share disposition. On June 1, 2026, 268.742 shares of ResMed common stock were surrendered at $190.57 per share to cover tax withholding on the vesting of Restricted Stock Units that were granted on June 1, 2023. This was a tax-withholding mechanism, not an open-market sale. After this transaction, Rider directly holds 9,488 shares of ResMed common stock, which includes 66.0288 shares purchased on April 30, 2026 through the ResMed Employee Stock Purchase Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Rider Michael J

Role Global General Counsel

Type	Security	Shares	Price	Value
Tax Withholding	ResMed Common Stock	268.742	$190.57	$51K

Holdings After Transaction: ResMed Common Stock — 9,488 shares (Direct, null)

Footnotes (1)

1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023. Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

Key Figures

Tax-withholding shares: 268.742 shares Tax-withholding price: $190.57 per share Post-transaction holdings: 9,488 shares +1 more

4 metrics

Tax-withholding shares 268.742 shares Shares delivered for tax withholding on RSU vesting on June 1, 2026

Tax-withholding price $190.57 per share Value per share for tax-withholding disposition

Post-transaction holdings 9,488 shares Common shares directly held after the transaction

ESPP shares included 66.0288 shares Purchased April 30, 2026 via ResMed Employee Stock Purchase Plan

Key Terms

Restricted Stock Units, Resmed Employee Stock Purchase Plan, tax-withholding disposition

3 terms

Restricted Stock Units financial

"Restricted Stock Units granted on 06/01/2023."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Resmed Employee Stock Purchase Plan financial

"shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan."

tax-withholding disposition financial

"transaction_action": "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rider Michael J

(Last) (First) (Middle)

9001 SPECTRUM CENTER BLVD

(Street)

SAN DIEGO CALIFORNIA 92123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RESMED INC [ RMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global General Counsel

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
ResMed Common Stock	06/01/2026		F		268.742(1)	D	$190.57	9,488(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 06/01/2023.

2. Includes 66.0288 shares of Resmed stock purchased on April 30, 2026 through the Resmed Employee Stock Purchase Plan.

	/s/ Michael J. Rider, Global General Counsel and Secretary	06/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ResMed (RMD) Global General Counsel Michael Rider report?

Michael J. Rider reported a tax-related share disposition. He surrendered 268.742 ResMed common shares at $190.57 each to cover withholding taxes on vesting Restricted Stock Units granted on June 1, 2023.

Was Michael Rider’s June 1, 2026 ResMed (RMD) transaction an open-market sale?

No, the June 1, 2026 transaction was not an open-market sale. Shares were delivered back to the issuer solely to satisfy tax withholding on vesting Restricted Stock Units granted in 2023.

How many ResMed (RMD) shares were used for Michael Rider’s tax withholding?

A total of 268.742 ResMed common shares were used for tax withholding. They were valued at $190.57 per share in connection with the vesting of previously granted Restricted Stock Units.

How many ResMed (RMD) shares does Michael Rider hold after this Form 4 transaction?

After the tax-withholding disposition, Michael J. Rider directly holds 9,488 ResMed common shares. This figure includes 66.0288 shares purchased through the ResMed Employee Stock Purchase Plan on April 30, 2026.

What role did Restricted Stock Units play in Michael Rider’s ResMed (RMD) Form 4 filing?

The filing reflects tax withholding on vesting Restricted Stock Units. Units granted on June 1, 2023 vested, and 268.742 shares were delivered to the issuer to satisfy associated tax obligations instead of being sold in the open market.

What is noted about the ResMed Employee Stock Purchase Plan in Michael Rider’s holdings?

Michael Rider’s reported holdings include 66.0288 ResMed shares purchased through the ResMed Employee Stock Purchase Plan. These shares were acquired on April 30, 2026 and form part of his total 9,488 directly held shares.